France / Français
Master Doctor Search:
Future of lupus management may require further disease subdivision
8 days ago - By Healio
DESTIN, Fla. - Systemic lupus erythematosus may benefit from being redefined and further subdivided, depending on the autoantibody profile of the patient, according to a speaker at the Congress of Clinical Rheumatology East 2022.
“I think it is very important when you have a newly diagnosed lupus patient that you perform an expanded antibody profile,” Elisabet Svenungsson, MD, PhD, an adjunct professor from the Karolinska Institute, in Sweden, told attendees. “This could help to tailor treatment to create better lives in the future. I believe that in the future, that we
Read more ...
The headlines of Master Doctor
FDA warns consumers to not eat certain Jif peanut butter because of...
Federal officials are recommending that the public not consume any of dozens of Jif brand peanut butter products because of a new outbreak of infections from Salmonella...
New engineered pandemic? US buys millions of vaccines as monkeypox outbreak...
An infectious disease called monkeypox is spreading throughout Europe and North America, raising fears of another pandemic. According to the Centers for Disease Control and...
VIDEO: CrossFit injuries are preventable with trainer involvement, attention...
BOULDER, Colo. - In this video from the International Extreme Sports Medicine Congress, Laura Vogel, MD, discussed incidence and prevention of common CrossFit injuries. “The...
Sex, tunnel size may increase arthrofibrosis risk after ACL reconstruction...
SAN FRANCISCO - Results presented here showed women were more likely to experience arthrofibrosis after ACL reconstruction with quadriceps tendon autograft compared with men...
US FDA Declines to Authorize Fluvoxamine for Covid-19 Treatment
Fluvoxamine, an antidepressant drug, was not approved by the US Food and Drug Administration for treating Covid-19.
COVID Cases Top 526.6 Million
Globally, COVID-19 cases have pinnacled 526.6 million, while the deaths have swelled to more than 6.28 million and vaccinations to over 11.43 billion.
First Treatment Approved for Eosinophilic Esophagitis
Dupilumab became the first drug approved to treat eosinophilic esophagitis in adults and pediatric patients ages 12 and older weighing at least 40 kg , the FDA...
Case report: Emphysematous cystitis may suggest ‘poor prognosis' in Crohn's...
The first reported incident of emphysematous cystitis in a patient with severe Crohn's disease, without UTI or fistulizing disease, may signal “poor prognosis” for these...
Expert says that doing a jive every day can reduce anxiety, help manage...
Dancing can reduce a person's levels of anxiety, along with providing other clinical benefits. A study from last year found that dancing can even help reduce symptoms of...
Medication for Drinking Addiction May Thwart Liver Disease
Individuals taking medication for alcohol use disorder were less likely to develop or experience progression of alcohol-related liver disease, a retrospective study...